# US Sialic Acid Market

> US Sialic Acid Market Size, Share, Industry Trend & Analysis Research Report Information by Form (Solid and Liquid), Application (Infant Nutrition, Dietary Supplements, Cosmetics and Personal Care and others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.97%
- **2024:** $ 121.68 Million
- **2025:** $ 130.16 Million
- **2035:** $ 255.33 Million
- **Key Players:** Fujifilm Wako Pure Chemical Corporation (JP), Sialix (US), Kerry Group (IE), Merck KGaA (DE), Sigma-Aldrich (US), Biolife Sciences (US), GlycoMar (GB), GlycoMimetics (US)

**Report ID:** MRFR/FnB/11366-HCR · **Pages:** 100 · **Author:** Garvit Vyas · **Last Updated:** May 04, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-sialic-acid-market-12891

---

## Market Summary

## us sialic acid market Overview

North America stands as the dominant force in the sialic acid market, claiming a substantial 53.08% share of the total market in 2018. Projected to experience a moderate growth rate during the forecast period from 2019 to 2024, the regional market's prominence is attributed to several factors. Chief among them is the presence of major manufacturers equipped with advanced extraction and purification technology for sialic acid. Additionally, the region benefits from the ready availability of diverse sources of sialic acid, including porcine, bovine, and ovine milk. The robust growth of the sialic acid market in North America is further fueled by the increasing demand for essential products such as infant formula, dietary supplements, and functional food and beverages. The region has witnessed a surge in health consciousness, with consumers actively seeking products that offer nutritional and functional benefits. This rising demand contributes significantly to the expansion of various end-use industries for sialic acid. One of the key drivers for the growth of the [sialic acid market](../../../reports/sialic-acid-market-7704) in North America is the demographic composition, with millennials emerging as a pivotal consumer segment. In 2015, millennials, aged 18 to 34 years, and Gen Xers, aged 35 to 50 years, each represented 34% of the workforce in the country. This substantial presence in the workforce positions millennials as a major consumer group for products enriched with sialic acid. The demand is further amplified by the significant number of working females in the age group of 25 to 40, contributing to the increasing consumption of infant milk formula. The high prevalence of working females in the specified age group underscores the changing dynamics of the workforce and its impact on consumer behavior. With more women actively participating in the workforce, there is an increased need for convenient and nutritionally rich alternatives, particularly in the realm of infant nutrition. This shift is a direct driver for the growing demand for infant milk formula, which often incorporates sialic acid to emulate the nutritional benefits of breast milk. Moreover, the expanding end-use industries for sialic acid in North America are closely linked to the region's rising per capita disposable incomes. As disposable incomes increase, consumers are more inclined to invest in products that offer health and wellness benefits. This trend contributes to the flourishing market for sialic acid in various applications, ranging from infant nutrition to dietary supplements and functional food and beverages.

## Market Drivers

### Rising Demand in Nutraceuticals

The sialic acid market is witnessing a notable increase in demand from the nutraceuticals sector. Sialic acid is recognized for its health benefits, including immune system support and cognitive function enhancement. As consumers become more health-conscious, the demand for functional ingredients in dietary supplements is on the rise. The nutraceuticals market in the US is expected to reach approximately $300 billion by 2025, with sialic acid playing a pivotal role in this growth. This trend suggests that the sialic acid market will continue to expand as manufacturers seek to incorporate sialic acid into their product formulations to meet consumer preferences for health-oriented products.

### Expansion of Research Activities

The sialic acid market is experiencing a boost due to the expansion of research activities in various scientific fields. Academic institutions and research organizations are increasingly focusing on the biochemical properties of sialic acid, exploring its potential applications in areas such as cancer research, immunology, and infectious diseases. This heightened research interest is likely to lead to new discoveries and innovations, thereby driving demand for sialic acid. Funding for research in the US is projected to increase, with federal and private investments supporting studies that could enhance the understanding of sialic acid's role in health and disease. Consequently, the sialic acid market stands to gain from these advancements as new applications are identified.

### Increasing Applications in Biotechnology

The sialic acid market is experiencing growth due to its expanding applications in biotechnology. Sialic acid is crucial in the development of biopharmaceuticals, particularly in the production of glycoproteins and monoclonal antibodies. These biopharmaceuticals are increasingly utilized in therapeutic treatments, which has led to a surge in demand for sialic acid. The biotechnology sector in the US is projected to grow at a CAGR of approximately 7.4% from 2025 to 2030, indicating a robust market for sialic acid. As research and development in this field intensifies, the sialic acid market is likely to benefit significantly from increased investments and innovations, further solidifying its role in the biopharmaceutical landscape.

### Growing Interest in Personalized Medicine

The sialic acid market is likely to benefit from the growing interest in personalized medicine. As healthcare shifts towards tailored treatments, the role of sialic acid in drug formulation and delivery systems becomes increasingly relevant. Personalized medicine aims to optimize therapeutic efficacy based on individual patient profiles, and sialic acid's unique properties may enhance drug targeting and reduce side effects. The personalized medicine market in the US is projected to grow significantly, potentially reaching $2 trillion by 2030. This growth indicates a promising future for the sialic acid market, as pharmaceutical companies may increasingly incorporate sialic acid into their personalized treatment strategies.

### Regulatory Support for Biopharmaceuticals

The sialic acid market is positively influenced by regulatory support for biopharmaceuticals in the US. Government agencies are increasingly providing frameworks that facilitate the development and approval of biopharmaceutical products, which often utilize sialic acid in their formulations. This regulatory environment encourages innovation and investment in the biopharmaceutical sector, leading to a higher demand for sialic acid. The US biopharmaceutical market is expected to grow to over $500 billion by 2025, indicating a substantial opportunity for the sialic acid market. As regulations continue to evolve, the market for sialic acid is likely to expand in tandem with the growth of biopharmaceuticals.

## Future Outlook

The [Sialic Acid Market](https://www.marketresearchfuture.com/reports/sialic-acid-market-7704) is projected to grow at a 6.97% CAGR from 2025 to 2035, driven by increasing demand in pharmaceuticals, food, and biotechnology sectors.

**New opportunities:**

- Developing sialic acid-based functional food products for health-conscious consumers. Investing in advanced extraction technologies to reduce production costs. Forming strategic partnerships with biotech firms for innovative applications in therapeutics.

By 2035, the sialic acid market is expected to achieve substantial growth and diversification.

## Segment Insights

### By Application: Pharmaceuticals (Largest) vs. Nutraceuticals (Fastest-Growing)

In the US sialic acid market, the application segment is dominated by pharmaceuticals, accounting for the largest share. This segment benefits from the rising demand for novel therapeutics and vaccines, with sialic acid being a key component that enhances drug efficacy. The food and beverage sector follows, driven by health-conscious consumers seeking functional ingredients, while cosmetics, although smaller, are gaining traction due to the increasing focus on natural beauty products. Nutraceuticals, while currently a smaller segment, are experiencing rapid growth as consumers become more health-oriented and seek supplements that promote wellness. The growth trends in the application segment are primarily influenced by an increasing awareness of health benefits associated with sialic acid. Pharmaceuticals remain the dominant force due to continuous investment in research and development, alongside an expanding pipeline of sialic acid-based drugs. Nutraceuticals are projected to be the fastest-growing segment, fueled by the surge in demand for dietary supplements and functional foods. The intersection of wellness trends and the scientific validation of sialic acid's benefits is driving innovation and expansion across all application areas.

Pharmaceuticals (Dominant) vs. Nutraceuticals (Emerging)

Pharmaceuticals represent the dominant application of sialic acid due to its essential role in drug formulation and delivery systems, enhancing therapeutic properties. This segment thrives on consistent innovation and substantial investments in R&D, focusing on treatments for various medical conditions. In contrast, nutraceuticals are classified as an emerging segment, primarily due to the increasing consumer shift towards preventive health measures and natural supplements. This sector is characterized by a burgeoning demand for products that support overall health and well-being. With sialic acid's ability to provide health benefits, nutraceuticals are becoming significant, appealing to health-conscious consumers and leveraging trends in wellness and functional foods to capture market share.

### By Source: Natural (Largest) vs. Synthetic (Fastest-Growing)

In the US sialic acid market, the distribution of market share between the natural and synthetic segments reveals a significant preference for natural sources. Natural sialic acid holds a larger portion of the market due to increasing demand for clean label products and consumer preference for naturally derived ingredients. This trend is reinforced by the growing awareness of the health benefits associated with natural ingredients, positioning the natural segment as the favored choice among manufacturers seeking to deliver quality without compromising on consumer expectations. Conversely, the synthetic segment is rapidly gaining traction, emerging as the fastest-growing area within the market. This growth can be attributed to advancements in production technologies and increasing applications in pharmaceuticals and nutraceuticals. As the industry evolves, synthetic sialic acid is being tapped for its cost-effectiveness and scalability, appealing to manufacturers looking for reliable and consistent product supply while catering to the rising demand in specialized applications.

Natural (Dominant) vs. Synthetic (Emerging)

Natural sialic acid is characterized by its derivation from natural sources such as animal tissues or certain plant extracts, making it highly regarded in the health food and dietary supplement sectors. Its dominant position is supported by consumer trends favoring health-conscious options and transparency in ingredient sourcing. In contrast, synthetic sialic acid is produced through chemical synthesis, allowing for greater consistency and cost competitiveness. This emerging segment is particularly appealing for manufacturers in the pharmaceutical space, where precision and reproducibility are essential. As the market for functional ingredients continues to expand, both natural and synthetic sialic acid are likely to coexist, catering to diverse consumer needs and preferences.

### By Form: Powder (Largest) vs. Liquid (Fastest-Growing)

In the US sialic acid market, the distribution among segment values is notably skewed towards the powder form, which holds the largest share. This form’s popularity can be attributed to its versatile applications, easy storage, and prolonged shelf life. On the other hand, the liquid form, while currently smaller in market share, has been gaining traction due to its convenience and immediate applicability in various sectors such as cosmetics and food products. Growth trends in this segment reflect a dynamic shift, particularly favoring the liquid form as a rapidly expanding choice. This evolution is driven by innovation in product development, alongside increasing consumer preferences for liquid formulations in dietary supplements and functional foods. The push for cleaner labels further bolsters the emergence of liquid sialic acid, appealing to health-conscious consumers looking for natural and easy-to-use solutions.

Powder (Dominant) vs. Liquid (Emerging)

The powder form of sialic acid remains the dominant segment in the market, largely due to its wide range of applications in pharmaceutical and nutraceutical industries. Its stability and ease of dosing make it a preferred choice for manufacturers and consumers alike. Conversely, the liquid form, recognized as an emerging segment, is gaining momentum as it aligns with modern consumer trends favoring ready-to-use products. Companies are increasingly investing in liquid formulations, which promise higher bioavailability and quicker absorption. This shift is indicative of evolving market demands, where convenience and versatility play crucial roles in driving product adoption.

### By End Use Industry: Healthcare (Largest) vs. Food Industry (Fastest-Growing)

In the US sialic acid market, the healthcare sector is the largest end-use industry, accounting for a significant market share due to the rising need for biologically functional ingredients in pharmaceuticals and health supplements. The food industry follows closely with a growing presence, driven by the increasing awareness of health benefits associated with sialic acid-enriched products, thus making it a compelling segment in the market. Growth trends in these segments are largely influenced by the expanding applications of sialic acid in the healthcare domain, where its role in drug delivery and immunology is increasingly recognized. Additionally, the food industry is witnessing a surge in demand for natural preservatives and flavor enhancers, making sialic acid a vital ingredient. The emergence of personal care products utilizing sialic acid for skin health also contributes to innovative applications, enhancing market appeal.

Healthcare (Dominant) vs. Personal Care (Emerging)

The healthcare sector stands out as the dominant player in the US sialic acid market, characterized by its substantial demand for sialic acid derivatives that are essential for various medical applications, including drug formulation and therapeutic solutions. High-quality sialic acid is prioritized for its biocompatibility and effectiveness in improving health outcomes. On the other hand, the personal care segment is emerging with innovative use cases as manufacturers seek to leverage sialic acid's benefits for skin hydration and anti-aging solutions. This segment is gaining traction among consumers who are increasingly inclined towards products with natural ingredients, signaling a shift in preferences that could shape its growth trajectory in the coming years.

## Competitive Benchmarking

The sialic acid market exhibits a dynamic competitive landscape characterized by innovation and strategic partnerships. Key players such as Sialix (US), Merck KGaA (DE), and Fujifilm Wako Pure Chemical Corporation (JP) are actively shaping the market through various operational strategies. Sialix (US) focuses on developing high-purity sialic acid for pharmaceutical applications, leveraging its advanced production techniques to cater to the growing demand for biopharmaceuticals. Meanwhile, Merck KGaA (DE) emphasizes its commitment to sustainability and digital transformation, integrating AI technologies into its production processes to enhance efficiency and reduce environmental impact. Fujifilm Wako Pure Chemical Corporation (JP) is also investing in research and development to expand its product portfolio, particularly in the area of glycomics, which is increasingly relevant in drug development and diagnostics.The business tactics employed by these companies reflect a moderately fragmented market structure, where localized manufacturing and supply chain optimization are pivotal. Companies are increasingly localizing their production facilities to mitigate supply chain disruptions and enhance responsiveness to market demands. This strategy not only reduces lead times but also allows for better alignment with regional regulatory requirements, thereby strengthening their competitive positions.
In October Sialix (US) announced a strategic partnership with a leading biopharmaceutical firm to co-develop a new line of sialic acid-based therapeutics. This collaboration is expected to leverage Sialix's expertise in sialic acid production and the partner's extensive distribution network, potentially accelerating the commercialization of innovative therapies. Such partnerships are indicative of a broader trend towards collaboration in the industry, as companies seek to combine resources and expertise to drive innovation.
In September Merck KGaA (DE) unveiled a new AI-driven platform aimed at optimizing its sialic acid production processes. This initiative is anticipated to enhance yield and reduce costs, positioning the company as a leader in sustainable production methods. The integration of AI not only streamlines operations but also aligns with the growing emphasis on sustainability within the market, reflecting a shift towards environmentally responsible practices.
In August Fujifilm Wako Pure Chemical Corporation (JP) expanded its research facilities in the US, focusing on glycomics and sialic acid applications. This expansion is likely to bolster the company's R&D capabilities, enabling it to respond more effectively to the increasing demand for sialic acid in various sectors, including pharmaceuticals and diagnostics. The investment underscores the importance of innovation in maintaining competitive advantage in a rapidly evolving market.
As of November the sialic acid market is increasingly influenced by trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing market presence. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards innovation, technological advancement, and supply chain reliability. This transition may redefine the competitive landscape, compelling companies to prioritize R&D and sustainable practices to meet the demands of a more discerning market.

## Report Scope

| MARKET SIZE 2024 | 121.68(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 130.16(USD Million) |
| MARKET SIZE 2035 | 255.33(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.97% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Fujifilm Wako Pure Chemical Corporation (JP), Sialix (US), Kerry Group (IE), Merck KGaA (DE), Sigma-Aldrich (US), Biolife Sciences (US), GlycoMar (GB), GlycoMimetics (US) |
| Segments Covered | Application, Source, Form, End Use Industry |
| Key Market Opportunities | Growing demand for sialic acid in pharmaceuticals and biotechnology presents lucrative market opportunities. |
| Key Market Dynamics | Rising demand for sialic acid in pharmaceuticals drives innovation and competitive dynamics in the market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of sialic acid in the US in 2024?**
A: The market valuation of sialic acid in the US was $121.68 Million in 2024.

**Q: What is the projected market valuation for sialic acid in the US by 2035?**
A: The projected market valuation for sialic acid in the US is $255.33 Million by 2035.

**Q: What is the expected CAGR for the US sialic acid market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US sialic acid market during the forecast period 2025 - 2035 is 6.97%.

**Q: Which application segment had the highest valuation in 2024 for sialic acid?**
A: In 2024, the Food and Beverage application segment had the highest valuation at $40.84 Million.

**Q: What are the two main sources of sialic acid in the US market?**
A: The two main sources of sialic acid in the US market are Natural and Synthetic, each valued at approximately $60.84 Million in 2024.

**Q: Which form of sialic acid is projected to have a higher valuation by 2035?**
A: By 2035, the Powder form of sialic acid is projected to have a higher valuation at $150.0 Million.

**Q: What was the valuation of the Personal Care end-use industry for sialic acid in 2024?**
A: The valuation of the Personal Care end-use industry for sialic acid was $40.42 Million in 2024.

**Q: Which key player in the sialic acid market is based in the US?**
A: Sialix and Sigma-Aldrich are key players in the sialic acid market based in the US.

**Q: What is the projected valuation for the Food Industry end-use segment by 2035?**
A: The projected valuation for the Food Industry end-use segment is $110.25 Million by 2035.

**Q: How does the valuation of the Healthcare end-use industry compare to the Food Industry in 2024?**
A: In 2024, the Healthcare end-use industry was valued at $30.42 Million, significantly lower than the Food Industry's $50.84 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-sialic-acid-market-12891*